The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Acetyl-4-morpholino-7-((4-(2-nitrophenyl)pyrimidin-2-yl)amino)-2H-chromen-2-one ID: ALA4777619
PubChem CID: 155677664
Max Phase: Preclinical
Molecular Formula: C25H21N5O6
Molecular Weight: 487.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)c1c(N2CCOCC2)c2ccc(Nc3nccc(-c4ccccc4[N+](=O)[O-])n3)cc2oc1=O
Standard InChI: InChI=1S/C25H21N5O6/c1-15(31)22-23(29-10-12-35-13-11-29)18-7-6-16(14-21(18)36-24(22)32)27-25-26-9-8-19(28-25)17-4-2-3-5-20(17)30(33)34/h2-9,14H,10-13H2,1H3,(H,26,27,28)
Standard InChI Key: RVGBAWZNWQFUGI-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
30.1521 -19.1297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1510 -19.9492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8590 -20.3582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5687 -19.9487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5658 -19.1261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8572 -18.7208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8588 -21.1754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1513 -21.5810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1507 -22.3974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8589 -22.8070 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.5690 -22.3942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5661 -21.5791 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.2781 -22.8005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.9844 -22.3896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6902 -22.7967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6798 -21.1623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9769 -21.5749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3938 -21.5684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3918 -22.3906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0989 -22.8012 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.8125 -22.3941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8146 -21.5719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1030 -21.1568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1039 -20.3396 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.5237 -21.1658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5187 -22.8055 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.2300 -21.5769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5266 -20.3486 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.8182 -19.9328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8210 -19.1192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1156 -18.7060 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.4056 -19.1126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4011 -19.9324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2794 -20.3557 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.9865 -19.9460 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.2807 -21.1729 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
11 13 1 0
13 14 1 0
14 15 2 0
15 19 1 0
18 16 1 0
16 17 2 0
17 14 1 0
18 19 2 0
18 23 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
22 25 1 0
21 26 2 0
25 27 1 0
25 28 2 0
24 29 1 0
24 33 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
34 35 2 0
34 36 1 0
4 34 1 0
M CHG 2 34 1 36 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 487.47Molecular Weight (Monoisotopic): 487.1492AlogP: 3.94#Rotatable Bonds: 6Polar Surface Area: 140.70Molecular Species: NEUTRALHBA: 10HBD: 1#RO5 Violations: ┄HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.57CX Basic pKa: 0.95CX LogP: 3.07CX LogD: 3.07Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.18Np Likeness Score: -1.14
References 1. Xu J,Li H,Wang X,Huang J,Li S,Liu C,Dong R,Zhu G,Duan C,Jiang F,Zhang Y,Zhu Y,Zhang T,Chen Y,Tang W,Lu T. (2020) Discovery of coumarin derivatives as potent and selective cyclin-dependent kinase 9 (CDK9) inhibitors with high antitumour activity., 200 [PMID:32447197 ] [10.1016/j.ejmech.2020.112424 ]